High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Abstract Background Breast cancer is rare in men, but management is focused on tumor characteristics commonly found in female breast cancer. The tumor microenvironment of male breast cancer is less well understood, and insight may improve male breast cancer management. The hepatocyte growth factor (...

Full description

Bibliographic Details
Main Authors: Si-Qi Qiu, Johan van Rooijen, Hilde H. Nienhuis, Bert van der Vegt, Hetty Timmer-Bosscha, Elise van Leeuwen-Stok, Annemiek M. E. Walenkamp, Carolien H. M. van Deurzen, Geertruida H. de Bock, Elisabeth G. E. de Vries, Carolien P. Schröder
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Breast Cancer Research
Subjects:
Male breast cancer
Hepatocyte growth factor (HGF)
Stromal cell-derived factor-1 (CXCL12)
Prognosis
Tumor biology
Online Access:http://link.springer.com/article/10.1186/s13058-020-01266-x

Internet

http://link.springer.com/article/10.1186/s13058-020-01266-x

Similar Items